| Catalog Number |
1550400-15 |
| Medical Device Problem Code |
Improper or Incorrect Procedure or Method (2017)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
11/04/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
G9: exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
|
| |
|
Event or Problem Description
|
|
It was reported that after implanting the xience sierra stent on (b)(6) 2019, it was noted to be expired.The patient is doing well.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for analysis.Reportedly, after implanting the xience sierra stent, it was noted to be expired.It should be noted that the xience alpine everolimus eluting coronary stent system instructions for use, states: do not use after the use by date.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported device expiration issue appears to be related to the use error.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
|
| |
|
Search Alerts/Recalls
|